Sputum eosinophils and bronchodilator reversibility: COPD or asthma?
作者信息
Currie Graeme P, Srivastava Prasima, Lee Daniel K C
出版信息
Chest. 2005 Jun;127(6):2292-3. doi: 10.1378/chest.127.6.2292-a.
PMID:15947359
Abstract
摘要
相似文献
1
Sputum eosinophils and bronchodilator reversibility: COPD or asthma?痰液嗜酸性粒细胞与支气管扩张剂可逆性：慢性阻塞性肺疾病还是哮喘？
Chest. 2005 Jun;127(6):2292-3. doi: 10.1378/chest.127.6.2292-a.
2
Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.慢性阻塞性肺疾病气道炎症与支气管扩张剂可逆性的特征：治疗的潜在指南
Chest. 2004 Aug;126(2):375-81. doi: 10.1378/chest.126.2.375.
3
Safety of sputum induction.痰液诱导的安全性。
Eur Respir J Suppl. 2002 Sep;37:9s-18s. doi: 10.1183/09031936.02.00000902.
4
Post-bronchodilator Reversibility of FEV and Eosinophilic Airway Inflammation in COPD.COPD 患者支气管扩张剂后 FEV 和嗜酸性气道炎症的可逆性。
Arch Bronconeumol. 2017 Oct;53(10):547-553. doi: 10.1016/j.arbres.2017.01.014. Epub 2017 Apr 21.
5
Clinical applications of assessment of airway inflammation using induced sputum.诱导痰气道炎症评估的临床应用
Eur Respir J Suppl. 2002 Sep;37:40s-43s. doi: 10.1183/09031936.02.00004002.
6
Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity.哮喘和慢性阻塞性肺疾病中的支气管扩张剂反应性或可逆性——需要明确界定。
Int J Chron Obstruct Pulmon Dis. 2018 Oct 23;13:3511-3513. doi: 10.2147/COPD.S183736. eCollection 2018.
7
[Bronchoalveolar lavage and induced sputum in asthmatic and COPD patient].[哮喘和慢性阻塞性肺疾病患者的支气管肺泡灌洗和诱导痰]
Pol Merkur Lekarski. 2003 Jun;14(84):545-7.
8
[Drug therapy of airway obstruction. "Completely different for asthma and COPD"].气道阻塞的药物治疗。“哮喘和慢性阻塞性肺疾病完全不同”
MMW Fortschr Med. 2008 May 15;150(20):14, 16.
9
Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.诱导痰和支气管肺泡灌洗作为评估吸入性糖皮质激素对哮喘患者疗效的工具。
J Lab Clin Med. 2000 Jul;136(1):39-49. doi: 10.1067/mlc.2000.107305.
10
[Tiotropium in asthma--a new opportunity?].噻托溴铵用于哮喘——新的契机？
Pneumologia. 2014 Oct-Dec;63(4):200-2.
Zotero 插件